Intuitive Surgical INC Form 4 insider transactions

Gary S Guthart, a Director of Intuitive Surgical Inc, sold 10,000 shares of common stock on August 11, 2026 for $400.00 per share.

Amy L Ladd, a Director of Intuitive Surgical Inc, sold 472 shares of common stock on August 10, 2026.

Gary Loeb, EVP & Chief Legal and Complian of Intuitive Surgical Inc, sold 400 shares of common stock on August 10, 2026 for $379.00 per share.

Mark Brosius, EVP & Chief Mfg and Supply Cha of Intuitive Surgical Inc, sold 56 shares of common stock on July 30, 2026.

Mark Brosius, EVP & Chief Mfg and Supply Cha of Intuitive Surgical Inc, sold 84 shares of common stock on July 27, 2026.

David J. Rosa, Chief Executive Officer (CEO) and a Director of Intuitive Surgical Inc, reported multiple transactions in common stock on July 10, 2026.

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 48 shares of common stock under a 10b5-1 plan.

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 69 shares of common stock via a 10b5-1 plan.

Gary Loeb, EVP & Chief Legal and Compliance Officer at Intuitive Surgical, sold 400 shares of common stock.

David J. Rosa, CEO of Intuitive Surgical Inc., reported transactions involving the acquisition and disposition of common stock and restricted stock units.

Jeddi Iman, SVP & GM da Vinci Platforms & at Intuitive Surgical Inc., reported transactions involving common stock and stock options on June 1, 2026, under a Rule 10b5-1 trading plan.

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 36 shares of common stock under a Rule 10b5-1 trading plan.

Intuitive Surgical EVP Mark Brosius sold 54 shares of common stock across three transactions under a Rule 10b5-1 trading plan.

Gary Loeb, EVP & Chief Legal and Compliance Officer at Intuitive Surgical, sold 400 shares of common stock.

Director Gary S. Guthart was granted 554 restricted stock units by Intuitive Surgical, Inc. on April 30, 2026.

Intuitive Surgical Director Monica Reed acquired 554 restricted stock units and converted 531 units into common stock as part of her annual compensation.

Intuitive Surgical director Jami Nachtsheim acquired 531 shares through RSU vesting and received a new grant of 554 RSUs.

Director Keith R. Leonard exercised restricted stock units and received a new grant of equity in Intuitive Surgical.

Intuitive Surgical Director Amy L. Ladd acquired 531 shares through RSU vesting and received a new grant of 554 RSUs.

Director Sreelakshmi Kolli acquired 531 shares of Intuitive Surgical common stock through the vesting of restricted stock units.

Director Amal M. Johnson acquired 531 shares of Intuitive Surgical common stock through the vesting of restricted stock units.

Director Lewis Chew acquired 531 shares of Intuitive Surgical common stock through the vesting of restricted stock units and was granted 554 new units.

Director Joseph C. Beery exercised restricted stock units and received a new grant of equity in Intuitive Surgical, Inc.

Intuitive Surgical Director Craig Barratt acquired 750 shares through RSU vesting and was granted 643 new restricted stock units.

Intuitive Surgical Director Amy L. Ladd executed trades involving common stock on April 28 and April 29, 2026, under a Rule 10b5-1 trading plan.

Intuitive Surgical SVP Mark Brosius sold 3,658 shares of common stock across three transactions in early March 2026 under a pre-arranged trading plan.

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported multiple transactions involving common stock and Restricted Stock Units, including sales under a 10b5-1 plan.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, sold a significant portion of her common stock holdings through a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's SVP & GM, Iman Jeddi, reported the vesting of Restricted Stock Units and Performance Stock Units, alongside related tax-driven share dispositions.

Intuitive Surgical Director Gary S. Guthart reported the vesting and subsequent tax-related sale of restricted and performance stock units.